MPLT
MPLT clinical trials: MapLight Therapeutics, Inc.
Every trial on ClinicalTrials.gov where MapLight Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 6
- Trials linked
- 6
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
MPLT on the catalyst calendar · MPLT registry changes
- Primary completion Mar 2029Sponsor estimatePhase 2NCT07459660An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease PsychosisMapLight Therapeutics · Psychosis Associated With Alzheimer's DiseaseEnrolling by invitationMPLTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2027Sponsor estimatePhase 2NCT06887192A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease PsychosisMapLight Therapeutics · Psychosis Associated With Alzheimer's DiseaseRecruitingMPLTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2030Sponsor estimatePhase 2NCT07459647A Long-Term Open-Label Study of ML-007C-MA in Adults With SchizophreniaMapLight Therapeutics · SchizophreniaRecruitingMPLTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2027Sponsor estimatePhase 2NCT05889273ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)MapLight Therapeutics · Autism Spectrum DisorderActive, not recruitingMPLTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 4, 2026ActualPhase 2NCT07038876A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With SchizophreniaMapLight Therapeutics · SchizophreniaCompletedMPLTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 10, 2026ActualPhase 2NCT05081245ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)MapLight Therapeutics · Autism Spectrum DisorderCompletedMPLTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 6 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner